UA66787C2 - A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds - Google Patents

A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds

Info

Publication number
UA66787C2
UA66787C2 UA99105491A UA99105491A UA66787C2 UA 66787 C2 UA66787 C2 UA 66787C2 UA 99105491 A UA99105491 A UA 99105491A UA 99105491 A UA99105491 A UA 99105491A UA 66787 C2 UA66787 C2 UA 66787C2
Authority
UA
Ukraine
Prior art keywords
preparation
methylpiperazine
ethoxyphenyl
pyrazolo
pyrimidine
Prior art date
Application number
UA99105491A
Other languages
English (en)
Inventor
Peter James Dann
Philippe Charles Levett
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10840421&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA66787(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of UA66787C2 publication Critical patent/UA66787C2/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
UA99105491A 1998-10-12 1999-10-08 A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds UA66787C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9822238.3A GB9822238D0 (en) 1998-10-12 1998-10-12 Process for preparation of pyrazolo[4,3-D]pyrimidin-7-ones and intermediates thereof

Publications (1)

Publication Number Publication Date
UA66787C2 true UA66787C2 (en) 2004-06-15

Family

ID=10840421

Family Applications (1)

Application Number Title Priority Date Filing Date
UA99105491A UA66787C2 (en) 1998-10-12 1999-10-08 A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds

Country Status (49)

Country Link
US (3) US6207829B1 (pl)
EP (1) EP0994115B1 (pl)
JP (1) JP3721021B2 (pl)
KR (1) KR100380954B1 (pl)
CN (2) CN1207295C (pl)
AP (1) AP1233A (pl)
AR (1) AR019244A1 (pl)
AT (1) ATE290003T1 (pl)
AU (1) AU756463B2 (pl)
BG (1) BG63205B1 (pl)
BR (1) BR9905092A (pl)
CA (1) CA2285733C (pl)
CO (1) CO5150214A1 (pl)
CR (1) CR6118A (pl)
CU (1) CU22928A3 (pl)
CZ (1) CZ296816B6 (pl)
DE (1) DE69923906T2 (pl)
DK (1) DK0994115T3 (pl)
DZ (1) DZ2912A1 (pl)
EA (1) EA003774B1 (pl)
EE (1) EE04192B1 (pl)
EG (1) EG22630A (pl)
ES (1) ES2237049T3 (pl)
GB (1) GB9822238D0 (pl)
GE (1) GEP20022700B (pl)
GT (1) GT199900172A (pl)
HK (1) HK1027559A1 (pl)
HR (1) HRP990318B1 (pl)
HU (1) HU226162B1 (pl)
ID (1) ID23351A (pl)
IL (11) IL132273A (pl)
IS (1) IS1951B (pl)
MA (1) MA25007A1 (pl)
MY (1) MY124620A (pl)
NO (1) NO313700B1 (pl)
OA (1) OA11165A (pl)
PE (1) PE20001086A1 (pl)
PL (1) PL198150B1 (pl)
PT (1) PT994115E (pl)
RS (1) RS49762B (pl)
SG (1) SG118060A1 (pl)
SI (1) SI0994115T1 (pl)
SK (1) SK285215B6 (pl)
TN (1) TNSN99189A1 (pl)
TR (1) TR199902541A2 (pl)
TW (1) TW589314B (pl)
UA (1) UA66787C2 (pl)
UY (1) UY25750A1 (pl)
ZA (1) ZA996412B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5204800A (en) * 1999-06-21 2001-01-09 Biochemical Pharmaceutical Factory of Zhuhai Sez, The Process for preparing sildenafil, and troche which comprises sildenafil and apomorphine
AU6259701A (en) * 2000-06-22 2002-01-02 Dunn Peter James Process for the preparation of pyrazolopyrimidinones
US6667398B2 (en) 2000-06-22 2003-12-23 Pfizer Inc Process for the preparation of pyrazolopyrimidinones
EP1176142A1 (en) * 2000-07-28 2002-01-30 Pfizer Inc. Process for the preparation of pyrazoles
US6407259B1 (en) 2000-07-28 2002-06-18 Pfizer Inc. Process for the preparation of pyrazoles
YU51701A (sh) * 2000-07-28 2003-12-31 Pfizer Inc. Postupak za dobijanje jedinjenja pirazola/4,3-d/ pirimidin-7-ona i njihovih derivata
PE20020394A1 (es) 2000-08-18 2002-06-21 Agouron Pharma Compuestos de pirazol y composiciones farmaceuticas que los contienen, que modulan y/o inhiben la actividad de erab/hadh2
ATE455758T1 (de) 2001-12-20 2010-02-15 Merck Serono Sa Pyrrolidin-derivatie als prostaglandin- modulatoren
WO2003059258A2 (en) * 2001-12-21 2003-07-24 Cytokinetics, Inc. Compositions and methods for treating heart failure
SI1509525T1 (sl) 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
WO2004072079A1 (en) * 2003-02-11 2004-08-26 Pfizer Limited Hydrated and anhydrous sildenafil hemi-citrate compound
ES2378620T3 (es) * 2003-03-27 2012-04-16 Cytokinetics, Inc. Sulfonamidas para el tratamiento de insuficiencia cardiaca congestiva, sus composiciones y usos.
CN100360531C (zh) * 2003-12-18 2008-01-09 中国人民解放军军事医学科学院放射与辐射医学研究所 用于预防或治疗阳萎和性冷淡的新吡唑并嘧啶类化合物
US20070010525A1 (en) * 2005-06-27 2007-01-11 Meyer Jackson Method and compositions for modulating neuropeptide hormone secretion
NL2000291C2 (nl) * 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
EP2024369A4 (en) * 2006-06-05 2010-10-27 Matrix Lab Ltd NEW PROCESS FOR THE PREPARATION OF SILDENAFIL CITRATE
CZ308056B6 (cs) * 2015-07-20 2019-11-27 Ustav Experimentalni Botaniky Av Cr V V I 5-Substituované-7-[4-(substituované)benzyl]amino-3-isopropylpyrazolo[4,3-d]pyrimidiny, jejich použití jako antirevmatika, a farmaceutické přípravky
WO2017168174A1 (en) 2016-04-02 2017-10-05 N4 Pharma Uk Limited New pharmaceutical forms of sildenafil
CN107759603B (zh) * 2016-08-18 2020-09-01 四川科伦药物研究院有限公司 一种杂环化合物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992441A (en) * 1972-12-26 1976-11-16 Pfizer Inc. Sulfamylbenzoic acids
GB9013750D0 (en) * 1990-06-20 1990-08-08 Pfizer Ltd Therapeutic agents
GB9612514D0 (en) * 1996-06-14 1996-08-14 Pfizer Ltd Novel process
SK285991B6 (sk) * 1997-04-25 2008-01-07 Pfizer Inc. Pyrazolopyrimidinóny, spôsob a medziprodukty na ich výrobu, ich použitie a farmaceutické a veterinárne kompozície na ich báze

Also Published As

Publication number Publication date
PL198150B1 (pl) 2008-05-30
NO994943L (no) 2000-04-13
GT199900172A (es) 2001-03-28
US6207829B1 (en) 2001-03-27
SK138599A3 (en) 2000-05-16
IL152928A0 (en) 2003-06-24
CN1255497A (zh) 2000-06-07
OA11165A (en) 2003-04-22
ZA996412B (en) 2001-04-11
HRP990318B1 (en) 2004-06-30
HUP9903469A2 (hu) 2000-08-28
SG118060A1 (en) 2006-01-27
ID23351A (id) 2000-04-13
IL152926A0 (en) 2003-06-24
IL152923A (en) 2004-02-08
DZ2912A1 (fr) 2004-03-01
HU9903469D0 (en) 1999-12-28
IL152927A (en) 2004-06-01
EP0994115A3 (en) 2000-05-24
US20010009962A1 (en) 2001-07-26
IL132273A0 (en) 2001-03-19
DE69923906D1 (de) 2005-04-07
TNSN99189A1 (fr) 2005-11-10
EA003774B1 (ru) 2003-08-28
AU756463B2 (en) 2003-01-16
IS5209A (is) 2000-04-13
EP0994115B1 (en) 2005-03-02
EA199900822A2 (ru) 2000-04-24
EA199900822A3 (ru) 2000-08-28
IL152924A (en) 2004-02-19
YU48999A (sh) 2002-06-19
IL152926A (en) 2004-02-19
PT994115E (pt) 2005-06-30
HRP990318A2 (en) 2000-06-30
CN1207295C (zh) 2005-06-22
PL335959A1 (en) 2000-04-25
ATE290003T1 (de) 2005-03-15
KR100380954B1 (ko) 2003-04-21
IL152927A0 (en) 2003-06-24
TW589314B (en) 2004-06-01
AP1233A (en) 2003-12-18
EE9900507A (et) 2000-06-15
EP0994115A2 (en) 2000-04-19
BR9905092A (pt) 2000-08-08
KR20000028987A (ko) 2000-05-25
UY25750A1 (es) 2001-08-27
NO313700B1 (no) 2002-11-18
TR199902541A2 (xx) 2000-07-21
DK0994115T3 (da) 2005-06-20
JP2000119273A (ja) 2000-04-25
CR6118A (es) 2005-09-16
EE04192B1 (et) 2003-12-15
AR019244A1 (es) 2001-12-26
AP9901672A0 (en) 1999-12-31
CN1473831A (zh) 2004-02-11
RS49762B (sr) 2008-04-04
CO5150214A1 (es) 2002-04-29
CZ296816B6 (cs) 2006-06-14
GEP20022700B (en) 2002-05-27
IS1951B (is) 2004-10-13
IL152928A (en) 2007-07-04
AU5358199A (en) 2000-04-13
HU226162B1 (en) 2008-05-28
GB9822238D0 (en) 1998-12-09
MY124620A (en) 2006-06-30
CA2285733C (en) 2004-08-24
ES2237049T3 (es) 2005-07-16
MA25007A1 (fr) 2000-07-01
IL152924A0 (en) 2003-06-24
DE69923906T2 (de) 2006-04-06
CZ353299A3 (cs) 2000-05-17
BG63205B1 (bg) 2001-06-29
CU22928A3 (es) 2004-02-20
IL152923A0 (en) 2003-06-24
JP3721021B2 (ja) 2005-11-30
NO994943D0 (no) 1999-10-11
US20030069422A1 (en) 2003-04-10
SK285215B6 (sk) 2006-09-07
IL132273A (en) 2004-06-20
BG103794A (en) 2000-09-29
SI0994115T1 (pl) 2005-08-31
CA2285733A1 (en) 2000-04-12
PE20001086A1 (es) 2000-10-18
HUP9903469A3 (en) 2000-10-30
HK1027559A1 (en) 2001-01-19
EG22630A (en) 2003-05-31

Similar Documents

Publication Publication Date Title
UA66787C2 (en) A process for the preparation of 1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidine-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine and intermediary compounds
HUT36328A (en) Fungicides containing 7-amino-azolo /1,5-a/ pyrimidine-derivatives and process for the production of the agents
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
MXPA02004448A (es) Derivados de imidazopiridina como inhibidores de la fosfodiesterasa vii.
MY117092A (en) Chemotherapeutic pyrrolocarbazole derivatives
ATE294779T1 (de) Arylpiperidinopropanol und arylpiperazinopropanol derivate und die selbe enthaltende pharmazeutika
PL328789A1 (en) Novel heterocyclic compounds, method of obtaining them, their application in production of a pharmaceutic agent and pharmaceutic agent obtained thereby
NZ500990A (en) 20(S) camptothecin glycoconjugates
BG103778A (en) Process for preparing pyrazole derivatives
CA2452036A1 (en) 6-'2-(phosphonomethoxy) alkoxy pyrimidine derivatives having antiviral activity
AU1465301A (en) Process for preparing n-(4-hydroxy-phenyl)-n'-(4'-aminophenyl)-piperazine
MX9604338A (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento que las contiene.
EP1092720A3 (en) Process for the preparation of pyrazolo [4,3-d] pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof
TR199900321T2 (xx) N-(1-nbutil - 4 - piperidil)metil) -3,4-dihidro -2H- (1,3) oksazino (3.2A) indol-10- Karboksamit haz�rlama prosesi ve prosesteki tuzlar ve ara �r�nler.
DE3477380D1 (en) Novel benzothiazepine derivatives, processes for preparing the same and pharmaceutical compositions
MY130190A (en) Method for the preparation of 4-halo-2'- nitrobutyrophenone compounds
AU3350195A (en) Bicyclic carboxamides as 5-HT-1A antagonists
AU7206898A (en) Method for producing 1,3-di-substituted 2-nitroguanidines
CA2245484A1 (en) Novel urea derivatives
WO2001077143A3 (en) Process for the preparation of 3-amino-1, 5-benzodiazepine derivatives
MY127737A (en) Novel process for the preparation of pyrazolopyrimidinones
HK1036978A1 (en) Enantioselective synthesis
CA2201219A1 (en) Process for the preparation of substituted pyrimidines
AP2000001960A0 (en) Process for the preparation of pyrazole(4,3-d)pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
AU4370489A (en) The use of oxidized polyamines, especially nn'-bis-(3- propionaldehyde)-1-4-diaminobutane (sperminedialdehyde) as immunosuppressive agents